Endothelin-1, Extracellular Volume Overload, and Hemodynamics in Hemodialysis Patients
American Journal of Hypertension · 2024
DOI: 10.1093/ajh/hpae060 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2024. Verfasst von Andrew Horvit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Endothelin-1, Renal Dialysis, Hemodynamics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: VA, Dedman Family Scholar in Clinical Care, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND Extracellular volume (ECV) overload and endothelial cell dysfunction are mortality risk factors in hemodialysis (HD) patients. Endothelin-1 (ET-1), an endothelium-derived vasoconstrictive peptide, is associated with poor outcomes in HD patients. We hypothesized there would be associations between ET-1 and ECV overload in hypertensive HD patients. METHODS We obtained pre-HD ET-1, ECV/weight (bioimpedance spectroscopy), pre-HD hemodynamics, and ambulatory blood pressure (BP) in an HD cohort. Following appropriate transformations, we conducted correlation and linear regression analyses idendifying associations between ET-1, ECV overload, total peripheral resistance index (TPRI), cardiac index (CI), and ambulatory BP. RESULTS Among 66 patients, median ET-1 was 1.93 (1.49–2.56) pg/ml. Median pre-HD ECV/weight, median TPRI, mean CI, and mean systolic ambulatory BP were 0.25 (0.22–0.30) l/kg, 3,161 (2,711–3,642) dynes × s/cm−5/m2, 2.92 (0.6) l/min/m2, and 143 (14) mm Hg, respectively. After reciprocal-transformation, ET-1 correlated with reciprocal-transformed ECV/weight (r = 0.3, P = 0.01), log-transformed TPRI (r = −0.3, P = 0.006), CI (r = 0.3, P = 0.009), and ambulatory BP (r = −0.3, P = 0.02). These associations persisted in linear regression analysis (β = 0.15, P = 0.002; β = −0.8, P = 0.002; β = 0.2, P = 0.002; β = −19, P = 0.03). CONCLUSIONS In hypertensive HD patients, ET-1 associates with ECV overload higher TPRI and ambulatory BP, and lower CI. Further research is necessary to determine if ECV reduction lowers ET-1 or if pharmacologic ET-1 antagonism can improve outcomes in HD patients with refractory ECV overload.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Dallas Veterans Affairs Medical Center, Medical Service, Nephrology Section Dallas, Texas, USA.
- Division of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
ORCID-Profile: Peter Noel Van Buren
Förderung
- VA
- Dedman Family Scholar in Clinical Care
- NIDDK NIH HHS
- National Institutes of Health NIDDK
- NCATS NIH HHS
- CSRD VA
- National Center for Advancing Translational Sciences of the National Institutes of Health
- Department of Veterans Affairs
Zitieren
APA
Horvit, A., Jeon-Slaughter, H., Sian, J., Roehm, B., & Van Buren, P. N. (2024). Endothelin-1, Extracellular Volume Overload, and Hemodynamics in Hemodialysis Patients. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpae060
Vancouver
Horvit A, Jeon-Slaughter H, Sian J, Roehm B, Van Buren PN. Endothelin-1, Extracellular Volume Overload, and Hemodynamics in Hemodialysis Patients. American Journal of Hypertension. 2024. doi:10.1093/ajh/hpae060
BibTeX
@article{Horvit2024,
author = {Horvit, Andrew and Jeon-Slaughter, Haekyung and Sian, Jaspreet and Roehm, Bethany and Van Buren, Peter Noel},
title = {Endothelin-1, Extracellular Volume Overload, and Hemodynamics in Hemodialysis Patients},
journal = {American Journal of Hypertension},
year = {2024},
doi = {10.1093/ajh/hpae060}
}
EUVIMED